| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3944206
Max Phase: Preclinical
Molecular Formula: C19H29NO
Molecular Weight: 287.45
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: C[C@@]12CC3CCC4C[C@H](O)CCC4C3CC1CC[C@H]2C#N
Standard InChI: InChI=1S/C19H29NO/c1-19-10-13-3-2-12-8-16(21)6-7-17(12)18(13)9-14(19)4-5-15(19)11-20/h12-18,21H,2-10H2,1H3/t12?,13?,14?,15-,16+,17?,18?,19+/m0/s1
Standard InChI Key: KDPTUCQFJFKZPA-VPGKROPNSA-N
Associated Targets(non-human)
GABA receptor alpha-4 subunit 24 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 287.45 | Molecular Weight (Monoisotopic): 287.2249 | AlogP: 4.14 | #Rotatable Bonds: 0 |
| Polar Surface Area: 44.02 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: | CX LogP: 3.42 | CX LogD: 3.42 |
| Aromatic Rings: 0 | Heavy Atoms: 21 | QED Weighted: 0.73 | Np Likeness Score: 1.88 |
References
| 1. (2016) Neuroactive substituted cyclopenta[b]phenanthrenes as modulators for GABA type-A receptors, |
Source
Source(1):